Business Context and Reporting Period
This Form 8-K, dated August 5, 2022, reports on Chardan NexTech Acquisition 2 Corp. (CNTQ), a Special Purpose Acquisition Company (SPAC) in the process of a business combination with Dragonfly Energy Holdings Corp. The filing details the results of a Special Meeting of stockholders held on August 5, 2022, regarding proposals to extend the deadline for completing the merger.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, or margin data for the reporting period. Key capital structure and transaction metrics include:
- Shares Outstanding: 15,812,500 shares of common stock as of the record date (July 11, 2022).
- Redemptions: Stockholders elected to redeem 9,556,652 shares, representing approximately 60.44% of issued and outstanding shares and 75.55% of shares sold in the IPO.
- Extension Funding: Insiders are authorized to deposit $200,000 per extension into the Trust Account to extend the business combination deadline.
- Securities: Units (CNTQU), Common Stock (CNTQ), and Redeemable Warrants (CNTQW) are registered on the NASDAQ Capital Market.
Material Changes and Voting Results
The primary material change is the approval of governance amendments to facilitate the merger with Dragonfly. At the Special Meeting, 11,331,512 shares (71.66% of voting power) were present. The stockholders approved three proposals:
- Proposal 1 (Charter Amendment): Approved to allow up to three one-month extensions of the business combination deadline.
- For: 9,502,515
- Against: 1,530,476
- Abstain: 298,521
- Proposal 2 (Trust Agreement Amendment): Approved to authorize the Trust Amendment Proposal.
- For: 6,340,015
- Against: 1,530,377
- Abstain: 298,521
- Proposal 3 (Adjournment): Approved to allow adjournment of the meeting if necessary for further proxy solicitation.
- For: 9,500,849
- Against: 1,532,141
- Abstain: 298,522
Outlook, Risks, and Management Commentary
Management and Dragonfly Energy have issued forward-looking statements regarding the business combination, noting that actual results may differ materially due to various risks. Key risks and contingencies identified include:
- Transaction Completion: Risks regarding the failure to obtain stockholder approval, satisfy closing conditions, or complete the merger by the deadline (even with extensions).
- Operational Risks: Inability to optimize or mass-produce solid-state cells, loss of key executives, and supply chain disruptions (specifically mentioning suppliers in China).
- Market and Regulatory: Changes in laws, failure to meet Nasdaq listing standards post-merger, and the impact of the pandemic or the Russian/Ukrainian conflict.
- Financing: Inability to complete the PIPE investment, term loan, or equity line (ChEF) required for the transaction.
Investor Verification Checklist
- Verify the final number of shares remaining after the 9,556,652 redemptions and the resulting cash balance in the Trust Account.
- Confirm the status of the $200,000 extension deposits by Insiders and whether any extensions have been triggered.
- Review the Definitive Proxy Statement (filed July 22, 2022) and Form S-4 for detailed terms of the Dragonfly merger and risk factors.
- Monitor the status of the PIPE investment and term loan financing, as their failure is a specific risk to closing the deal.
- Check for any subsequent filings regarding the timeline for the business combination given the high redemption rate.